Sponsor or institution
Clinical trials and research at Changchun Intellicrown Pharmaceutical Co. LTD
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Changchun Intellicrown Pharmaceutical Co. LTD that are recruiting, at sites in 2 countries (most in China (2), United States (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Evaluating the safety and effects of IMM-H014 in healthy individuals
This study is testing a new drug called IMM-H014 in healthy people to see if it's safe and how it behaves in the body.
-
ZZ06 for adults with advanced EGFR‑positive solid tumors
This trial will test whether the drug ZZ06 is safe and can control tumor growth in adults with advanced EGFR‑positive solid tumors who have no standard treatment options.
Quick answers
How many clinical trials run by Changchun Intellicrown Pharmaceutical Co. LTD are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (2 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.